EDGAR Filing Documents for 0001144204-17-043154

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001144204-17-043154

Filing Date

2017-08-14

Accepted

2017-08-14 16:12:41

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	v471078_10q.htm	10-Q	564874
2	EXHIBIT 10.4	v471078_ex10-4.htm	EX-10.4	41427
3	EXHIBIT 10.5	v471078_ex10-5.htm	EX-10.5	63058
4	EXHIBIT 31.1	v471078_ex31-1.htm	EX-31.1	11396
5	EXHIBIT 31.2	v471078_ex31-2.htm	EX-31.2	11376
6	EXHIBIT 32.1	v471078_ex32-1.htm	EX-32.1	5644
7	EXHIBIT 32.2	v471078_ex32-2.htm	EX-32.2	5708
14	GRAPHIC	image_001.jpg	GRAPHIC	3267
	Complete submission text file	0001144204-17-043154.txt		4964293

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	aphb-20170630.xml	EX-101.INS	1329932
9	XBRL TAXONOMY EXTENSION SCHEMA	aphb-20170630.xsd	EX-101.SCH	36663
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	aphb-20170630_cal.xml	EX-101.CAL	41439
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	aphb-20170630_def.xml	EX-101.DEF	140917
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	aphb-20170630_lab.xml	EX-101.LAB	269882
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	aphb-20170630_pre.xml	EX-101.PRE	273997

Mailing Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130

Business Address 3579 VALLEY CENTRE DRIVE SAN DIEGO CA 92130 804-827-2524

AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)